ReGen 2025 Conference on Regenerative Medicine Begins with Launch of India’s First Guidelines for Platelet-Rich Plasma Therapy

▴ ReGen 2025
Attracting over 500 delegates and 60+ speakers from around the world, the second edition of the summit spotlighted cutting-edge advances in regenerative medicine.

Hello! If you're looking for high-quality genericmedications, fast delivery and excellent customer service, ourstore is the right choice for you. With over 20 years of onlineexperience, we guarantee safe, effective products that are alwaysin stock. Delivery within 48 hours, free shipping from $200, and 100% money-back guarantee if your order doesn't arrive on time.

👉 Order now at BestCheapPills and discover exclusive discounts for registeredcustomers!

Chennai, 02 August 2025: The second edition of ReGen 2025, a two-day international conference on regenerative medicine, orthobiologics, pain management, and sports injury rehabilitation, commenced today in Chennai, drawing over 500 healthcare professionals from across India and abroad. The event marked a significant milestone in India’s medical landscape with the launch of the country’s first-ever Platelet-Rich Plasma (PRP) Guidelines, a standardised, evidence-based framework for PRP therapy, a transformative blood-based treatment for orthopedic, sports-related, and degenerative conditions.

Regenerative Medicine is a field of medicine that focuses on repairing, regenerating, or replacing damaged cells, tissues, or organs using the body’s natural healing processes. PRP therapy uses a concentrated dose of a patient’s own platelets to accelerate healing of injured tissues.

The conference featured more than 60 speakers and panellists, including global stalwarts in regenerative medicine, and hosted over 25 high-impact plenary and interactive sessions on various aspects of regenerative medicine, which focuses on harnessing the body’s natural healing abilities to repair or replace damaged cells, tissues, and organs with growing promise across orthopedic, neurological, and musculoskeletal applications.

As part of the ReGen 2025 conference, a one-day hands-on workshop was conducted yesterday at the Tamil Nadu Government Multi Super Speciality Hospital in the city, offering participants direct exposure to imaging-guided regenerative treatment procedures, case-based discussions, and live demonstrations of best practices in regenerative therapy.

In her comments at the inaugural session of the conference, Dr. Sharmila Tulpule, Consultant Orthopedic Surgeon & Regenerative Medicine Specialist and Founder Director - Orthobiologix Clinic, and the Chairperson of ReGen 2025 said, “We are proud to host ReGen 2025, a landmark gathering that brings together some of the brightest minds in regenerative medicine from India and across the world. As regenerative medicine rapidly evolves into one of the most promising frontiers in healthcare, conferences like this play a vital role in accelerating research, clinical adoption, and policy alignment. ReGen 2025 proved itself as a dynamic platform for knowledge exchange, hands-on learning, and global collaboration. From keynote lectures on gene editing and tissue engineering to live workshops, research sessions, and an innovation showcase, ReGen 2025 is designed to shape the future of biologic therapies in India. The unveiling of India’s first PRP guidelines at the conference is a major milestone.”

In his comments, Dr. G. K. Kumar, Professor and Head, Department of Anesthesia & Pain Medicine, Tamil Nadu Government Multi Super Speciality Hospital, Chennai, said, “The launch of India’s first-ever PRP guidelines marks a turning point for regenerative medicine in the country. Though PRP therapy has become a cornerstone of biologic treatment worldwide, the standardised protocols were absent in India. It led to inconsistent practices and outcomes. However, these newly released guidelines fill that critical gap by providing a comprehensive, evidence-based framework. With a strong focus on patient-centered care, the guidelines also emphasise informed consent and long-term follow-up. Rigorously developed by 17 leading experts and validated through, this landmark document sets a new benchmark for clinical excellence in India’s regenerative practices with the highest global standards.”

Talking about the conference, Mr. Niteen Tulpule, Co-Founder & Director, Orthobiologix Biotech Pvt. Ltd,, said, “The topics covered included cutting-edge regenerative procedures and technologies, including autologous blood products, which are therapies derived from the patient’s own blood to stimulate healing; allogenic cell therapy, which refers to the use of donor cells to repair or regenerate tissue; growth factor therapies that are applications of bioactive proteins to promote tissue regeneration, and bone marrow aspirate concentrate, a potent source of stem cells used in musculoskeletal and cartilage repair. These technologies are rapidly reshaping clinical protocols by offering minimally invasive, personalised solutions to chronic pain, sports injuries, and degenerative diseases, reducing recovery time and improving long-term outcomes.”

In his address, Dr A Navaladishankar, Senior Consultant Orthopaedic Surgeon, Apollo Hospital Chennai, said, “The release of these PRP guidelines at ReGen 2025 is not just a scientific achievement. It’s a rallying point for India’s entire regenerative medicine ecosystem. With our vast clinical expertise and growing patient base, India is uniquely positioned to lead in the global regenerative movement. These guidelines lay the foundation for safe, standardised, and evidence-based care. We urge clinicians, researchers, and policymakers to embrace this moment as a turning point in how we approach healing and patient care.”

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026